MedTrace Logo

Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study

NCT04935866 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 286

Last updated 2022-08-18

No results posted yet for this study

Summary

The NeurO2 study is a multicenter observational study looking at NIRS monitoring in neurocrocritically ill patients during the acute phase of care following an acute brain injury. The study is nested within the HEMOTION Trial and the SAHaRA Trial

Conditions

Interventions

OTHER

Near-infrared spectroscopy (NIRS)

Non invasive brain oxygenation monitoring with Near-Infrared Spectroscopy (NIRS) technology. Patients enrolled in the NeurO2 study will have bilateral NIRS sensors applied to the forehead according to manufacturer recommendations. Data will be monitored continuously throughout the study intervention in the parent trials (HEMOTION and SAHaRA trials) in the neurocritical care unit. Data will be extracted from the device at the end of the study period.

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    collaborator OTHER

  • Canadian Critical Care Trials Group

    collaborator OTHER

  • Canadian Traumatic Brain Injury Research Consortium

    collaborator UNKNOWN

  • CHU de Quebec-Universite Laval

    lead OTHER

Principal Investigators

  • Alexis F Turgeon, MD MSc FRCPC · CHU de Québec-Universite Laval Research Center, Universite Laval

  • Shane W English, MD MSc FRCPC · Ottawa Hospital Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-07
Primary Completion
2024-07-31
Completion
2025-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04935866 on ClinicalTrials.gov